Novo Nordisk Archives | the deep dive

the deep dive

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Novo Nordisk

$450 Error Nukes Novo Nordisk’s Ozempic Patent, Opening Canada To Generics

Big Food Scrambles to Adapt as Weight Loss Drugs Transform Appetites

Study Examines Vision Loss Reports in Patients Taking GLP-1 Drugs

Novo Nordisk Shares Surge After Next-Gen Obesity Drug Shows 22% Weight Loss

People Are Overdosing On Ozempic and Its Off-Brand Versions

Can Ozempic Topple Fast Food Demand?

Denmark’s GDP Gets A Big Boost From Ozempic

Is Ozempic the New Wonder Drug?

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos